NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹2,236 Cr | ₹2,247 Cr | ₹1,795 Cr | ₹1,681 Cr | ₹1,448 Cr |
What is the latest Total Expenditure of NATCO PHARMA ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹2,236 Cr |
| Mar2024 | ₹2,247 Cr |
| Mar2023 | ₹1,795 Cr |
| Mar2022 | ₹1,681 Cr |
| Mar2021 | ₹1,448 Cr |
How is Total Expenditure of NATCO PHARMA Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,236 Cr | -0.52 | |
| Mar2024 | ₹2,247 Cr | 25.18 | |
| Mar2023 | ₹1,795 Cr | 6.79 | |
| Mar2022 | ₹1,681 Cr | 16.09 | |
| Mar2021 | ₹1,448 Cr | - | |
Compare Total Expenditure of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹16,325.0 Cr | -0.6% | -7.3% | -1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,530.0 Cr | -0.4% | 0.9% | 19.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹219,675.0 Cr | -1.2% | 21.1% | 29.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,970.0 Cr | -2.3% | 0.3% | 34.8% | Stock Analytics | |
| CIPLA | ₹117,947.0 Cr | 0.7% | 1.5% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,601.2 Cr | -0.3% | -7.1% | -3.9% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -0.6% |
-7.3% |
-1% |
| SENSEX | -0.1% |
2.4% |
-3.3% |
You may also like the below Video Courses